Engraftment Syndrome Following Autologous Stem Cell Transplantation in a Patient Receiving Nivolumab as Salvage Therapy
Open Access
- 11 June 2025
- journal article
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 42 (4) , 324-326
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practiceAnnals of Hematology, 2025
- Engraftment Syndrome, an Unusual Complication during Autologous Peripheral Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients Receiving Checkpoint Inhibitors As Salvage Therapy in the Pre-Transplant SettingBlood, 2024
- Engraftment Syndrome in Autologous Hematopoietic Stem Cell Transplant Patients: Incidence, Associated Risk Factors, Features, and OutcomesAnnals of Transplantation, 2024
- Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multi-Center Retrospective AnalysisBlood, 2023
- Engraftment Syndrome Incidence after Immune Checkpoint Inhibitor Therapy in Pts with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Single Institutional ReviewBlood, 2023
- The Impact of Prior Salvage Treatment With Immune Checkpoint Inhibitors on Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Single-Center ExperienceClinical Lymphoma Myeloma and Leukemia, 2021
- Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management ApproachTransplantation and Cellular Therapy, 2015
- Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteriaBone Marrow Transplantation, 2003
- Engraftment syndrome following hematopoietic stem cell transplantationBone Marrow Transplantation, 2001